FIELD: pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents a drug composition in form of solution for intravenous and/or intramuscular introduction, containing ethyl-methyl-hydroxypyridine succinate as an active agent and excipients, characterised by that contains as an auxiliary components potassium metabisulphite and high-purity water for injections in the following proportions: ethyl-methyl-hydroxypyridine succinate - 45-55.0 mg, potassium metabisulphite (potassium disulfite) - 0.45-2.0 mg, water for injections - up to 1.0 ml, at pH from 4.0 to 5.0, as well as method of producing composition.
EFFECT: invention provides efficient, safe and high-purity solution for injections, high stability of the preparation.
3 cl, 3 ex, 1 tbl
